Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Testicular Neoplasms 2Teratoma 1Seminoma 1Sarcoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Hearing Loss 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Filgrastim 10Carboplatin 10Ifosfamide 9Paclitaxel 8Peripheral Blood Stem Cell Transplantation 7Etoposide 7X-Rays 5Specimen Handling 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Thiotepa 4Nuclear Medicine Department, Hospital 4Melphalan 4Cisplatin 4Busulfan 4Biopsy 4pegfilgrastim 3etoposide phosphate 3Temozolomide 3Granulocyte Colony-Stimulating Factor 3tazemetostat 2olaparib 2larotrectinib 2ixabepilone 2erdafitinib 2ensartinib 2Vemurafenib 2Stem Cell Transplantation 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × sodium thiosulfate × Genitourinary × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡